User login
VESAP4 Now Available
The updated and improved VESAP4 is now available for purchase, in time for those preparing for qualification, certification and recertification exams.
A major enhancement of this fourth edition of the Vascular Education and Self-Assessment Program (VESAP) is the companion app – Apple products only – which lets users access the program off-line, in virtually any setting, and then later sync with the desktop version. The companion app will be available later this month.
VESAP4 also includes improved and simplified navigation, expanded bookmarking and annotation and easier certificate tracking.
Please note: VESAP3 expires at 11:59 p.m. Eastern Daylight Time on Sept. 1. Owners can continue to use it in learning mode until Sept. 15, but will no longer be able to claim credits. VESAP4 will expire July 31, 2020.
The updated and improved VESAP4 is now available for purchase, in time for those preparing for qualification, certification and recertification exams.
A major enhancement of this fourth edition of the Vascular Education and Self-Assessment Program (VESAP) is the companion app – Apple products only – which lets users access the program off-line, in virtually any setting, and then later sync with the desktop version. The companion app will be available later this month.
VESAP4 also includes improved and simplified navigation, expanded bookmarking and annotation and easier certificate tracking.
Please note: VESAP3 expires at 11:59 p.m. Eastern Daylight Time on Sept. 1. Owners can continue to use it in learning mode until Sept. 15, but will no longer be able to claim credits. VESAP4 will expire July 31, 2020.
The updated and improved VESAP4 is now available for purchase, in time for those preparing for qualification, certification and recertification exams.
A major enhancement of this fourth edition of the Vascular Education and Self-Assessment Program (VESAP) is the companion app – Apple products only – which lets users access the program off-line, in virtually any setting, and then later sync with the desktop version. The companion app will be available later this month.
VESAP4 also includes improved and simplified navigation, expanded bookmarking and annotation and easier certificate tracking.
Please note: VESAP3 expires at 11:59 p.m. Eastern Daylight Time on Sept. 1. Owners can continue to use it in learning mode until Sept. 15, but will no longer be able to claim credits. VESAP4 will expire July 31, 2020.
This Month in CHEST: Editor’s picks
Giants in Chest Medicine:
Steven E. Weinberger, MD, FCCP
By Dr. J. Mandel
Editorial
Precision Medicine Urgency: The Case of Inhaled Corticosteroids in COPD By Drs. S. Suissa and P. Ernst
Original Research
Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation By Dr. N. T. Tanner, et al.
The Long-Term Effect of Bacille Calmette-Guérin Vaccination on Tuberculin Skin Testing: A 55-Year Follow-Up Study By Dr. J. D. Mancuso, et al.
Clinical Characteristics of Pertussis-Associated Cough in Adults and Children: A Diagnostic Systematic Review and Meta-Analysis By Dr. A. Moore, et al.
Giants in Chest Medicine:
Steven E. Weinberger, MD, FCCP
By Dr. J. Mandel
Editorial
Precision Medicine Urgency: The Case of Inhaled Corticosteroids in COPD By Drs. S. Suissa and P. Ernst
Original Research
Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation By Dr. N. T. Tanner, et al.
The Long-Term Effect of Bacille Calmette-Guérin Vaccination on Tuberculin Skin Testing: A 55-Year Follow-Up Study By Dr. J. D. Mancuso, et al.
Clinical Characteristics of Pertussis-Associated Cough in Adults and Children: A Diagnostic Systematic Review and Meta-Analysis By Dr. A. Moore, et al.
Giants in Chest Medicine:
Steven E. Weinberger, MD, FCCP
By Dr. J. Mandel
Editorial
Precision Medicine Urgency: The Case of Inhaled Corticosteroids in COPD By Drs. S. Suissa and P. Ernst
Original Research
Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation By Dr. N. T. Tanner, et al.
The Long-Term Effect of Bacille Calmette-Guérin Vaccination on Tuberculin Skin Testing: A 55-Year Follow-Up Study By Dr. J. D. Mancuso, et al.
Clinical Characteristics of Pertussis-Associated Cough in Adults and Children: A Diagnostic Systematic Review and Meta-Analysis By Dr. A. Moore, et al.
CHEST Membership News
Introducing CHEST Participation Points
Everyday, you commit your time to helping patients. We recognize your dedication not only to your profession but to the CHEST community.
We’re happy to introduce CHEST Participation Points, designed to increase member recognition and reward you for participating and contributing to our diverse community. Wherever you are in your career, you can earn points for the things you do within the CHEST community.
Once you receive 50, 100, or 150 points, you can redeem your points for CHEST-branded apparel or discounts on courses and products.
Point accrual started on July 5, so you’ve already been earning points. If you are an FCCP, you began with 30 points awarded for becoming FCCP—that’s only 20 points away from the first tier of prizes. To accrue or redeem points, you must be an active member and current with your dues.
Log in to your CHEST account, and access Participation Points in the left column to see your points.
Start earning more points today! Learn more at chestnet.org/participationpoints.
Introducing CHEST Participation Points
Everyday, you commit your time to helping patients. We recognize your dedication not only to your profession but to the CHEST community.
We’re happy to introduce CHEST Participation Points, designed to increase member recognition and reward you for participating and contributing to our diverse community. Wherever you are in your career, you can earn points for the things you do within the CHEST community.
Once you receive 50, 100, or 150 points, you can redeem your points for CHEST-branded apparel or discounts on courses and products.
Point accrual started on July 5, so you’ve already been earning points. If you are an FCCP, you began with 30 points awarded for becoming FCCP—that’s only 20 points away from the first tier of prizes. To accrue or redeem points, you must be an active member and current with your dues.
Log in to your CHEST account, and access Participation Points in the left column to see your points.
Start earning more points today! Learn more at chestnet.org/participationpoints.
Introducing CHEST Participation Points
Everyday, you commit your time to helping patients. We recognize your dedication not only to your profession but to the CHEST community.
We’re happy to introduce CHEST Participation Points, designed to increase member recognition and reward you for participating and contributing to our diverse community. Wherever you are in your career, you can earn points for the things you do within the CHEST community.
Once you receive 50, 100, or 150 points, you can redeem your points for CHEST-branded apparel or discounts on courses and products.
Point accrual started on July 5, so you’ve already been earning points. If you are an FCCP, you began with 30 points awarded for becoming FCCP—that’s only 20 points away from the first tier of prizes. To accrue or redeem points, you must be an active member and current with your dues.
Log in to your CHEST account, and access Participation Points in the left column to see your points.
Start earning more points today! Learn more at chestnet.org/participationpoints.
CHEST ® journal — new online home
We are excited to share that the journal CHEST® has a new website with improved navigation, better search capabilities, alert sign-ups, and more multimedia elements. We are asking members to take a few minutes to activate their new account.
In order to maintain continuous access to the online journal, members will have to register for a free account and claim their subscription. If you go to chestjournal.org, CHEST members can then complete a 1- to 2-minute registration process.
CHEST members should have received an email with step-by-step instructions. Still have questions or need help? Contact Online Journal Support at 800/654-2452 (US and Canada) or +44 (0) 1865-843177 (Europe).
We are excited to share that the journal CHEST® has a new website with improved navigation, better search capabilities, alert sign-ups, and more multimedia elements. We are asking members to take a few minutes to activate their new account.
In order to maintain continuous access to the online journal, members will have to register for a free account and claim their subscription. If you go to chestjournal.org, CHEST members can then complete a 1- to 2-minute registration process.
CHEST members should have received an email with step-by-step instructions. Still have questions or need help? Contact Online Journal Support at 800/654-2452 (US and Canada) or +44 (0) 1865-843177 (Europe).
We are excited to share that the journal CHEST® has a new website with improved navigation, better search capabilities, alert sign-ups, and more multimedia elements. We are asking members to take a few minutes to activate their new account.
In order to maintain continuous access to the online journal, members will have to register for a free account and claim their subscription. If you go to chestjournal.org, CHEST members can then complete a 1- to 2-minute registration process.
CHEST members should have received an email with step-by-step instructions. Still have questions or need help? Contact Online Journal Support at 800/654-2452 (US and Canada) or +44 (0) 1865-843177 (Europe).
New Tools in Campaign to Fight Asthma
The Allergy & Asthma NetWork, the nation’s leading patient education and advocacy organization for people with allergy and asthma, has once again joined forces with the CHEST Foundation in an effort to empower patients suffering from severe asthma.
The campaign’s focus is to educate health-care providers, patients, parents of asthmatics, and the public about the most current treatment options for asthma, highlight the importance of referring to specialists to improve patient outcomes, and bring to light the role of the entire health-care team in the care of a patient with severe or difficult-to-control asthma.
Severity Assessment Tool
Available online and in print, the severity assessment tool was designed to help a patient, and the clinician, understand the severity of their asthma. Not only does the tool evaluate the severity of their condition, but it also helps the patient become more aware of their symptoms. The seven-question assessment includes questions on usage of quick-relief or rescue inhalers, visits to the ED/hospital, physical activity, controller medication, and quality of sleep.
Patient and Caregiver Testimonials
The campaign features several patient and caregiver testimonials that tell the stories of patients and parents of children with severe asthma.
“What we want people to understand, is that at the time of Ben’s passing, he was on a preventive med. He was going to the doctor routinely. We had actually just been to the asthma doctor. We were seeing somebody, had an action plan, and everybody knew what they had to do. Even with all of that, it still came to this. Benjamin still lost his life, and we never knew this was something that could happen,” stated Cristin Buckley, mother of Benjamin Buckley who was 7 years old at the time of his death. These testimonial videos will be used to raise awareness of the condition, and the importance of managing and monitoring symptoms.
Shared Decision Making Tool
Thank You to Our Supporters
The CHEST Foundation and Allergy and Asthma Network would like to thank our generous supporters, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, and Novartis for making this campaign possible. It is through supporters, who are active participants in helping grow this campaign, that these important materials are able to have an impact on patient outcomes and create long-lasting social change.
To view the campaign materials, visit us at asthma.chestnet.org.
The Allergy & Asthma NetWork, the nation’s leading patient education and advocacy organization for people with allergy and asthma, has once again joined forces with the CHEST Foundation in an effort to empower patients suffering from severe asthma.
The campaign’s focus is to educate health-care providers, patients, parents of asthmatics, and the public about the most current treatment options for asthma, highlight the importance of referring to specialists to improve patient outcomes, and bring to light the role of the entire health-care team in the care of a patient with severe or difficult-to-control asthma.
Severity Assessment Tool
Available online and in print, the severity assessment tool was designed to help a patient, and the clinician, understand the severity of their asthma. Not only does the tool evaluate the severity of their condition, but it also helps the patient become more aware of their symptoms. The seven-question assessment includes questions on usage of quick-relief or rescue inhalers, visits to the ED/hospital, physical activity, controller medication, and quality of sleep.
Patient and Caregiver Testimonials
The campaign features several patient and caregiver testimonials that tell the stories of patients and parents of children with severe asthma.
“What we want people to understand, is that at the time of Ben’s passing, he was on a preventive med. He was going to the doctor routinely. We had actually just been to the asthma doctor. We were seeing somebody, had an action plan, and everybody knew what they had to do. Even with all of that, it still came to this. Benjamin still lost his life, and we never knew this was something that could happen,” stated Cristin Buckley, mother of Benjamin Buckley who was 7 years old at the time of his death. These testimonial videos will be used to raise awareness of the condition, and the importance of managing and monitoring symptoms.
Shared Decision Making Tool
Thank You to Our Supporters
The CHEST Foundation and Allergy and Asthma Network would like to thank our generous supporters, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, and Novartis for making this campaign possible. It is through supporters, who are active participants in helping grow this campaign, that these important materials are able to have an impact on patient outcomes and create long-lasting social change.
To view the campaign materials, visit us at asthma.chestnet.org.
The Allergy & Asthma NetWork, the nation’s leading patient education and advocacy organization for people with allergy and asthma, has once again joined forces with the CHEST Foundation in an effort to empower patients suffering from severe asthma.
The campaign’s focus is to educate health-care providers, patients, parents of asthmatics, and the public about the most current treatment options for asthma, highlight the importance of referring to specialists to improve patient outcomes, and bring to light the role of the entire health-care team in the care of a patient with severe or difficult-to-control asthma.
Severity Assessment Tool
Available online and in print, the severity assessment tool was designed to help a patient, and the clinician, understand the severity of their asthma. Not only does the tool evaluate the severity of their condition, but it also helps the patient become more aware of their symptoms. The seven-question assessment includes questions on usage of quick-relief or rescue inhalers, visits to the ED/hospital, physical activity, controller medication, and quality of sleep.
Patient and Caregiver Testimonials
The campaign features several patient and caregiver testimonials that tell the stories of patients and parents of children with severe asthma.
“What we want people to understand, is that at the time of Ben’s passing, he was on a preventive med. He was going to the doctor routinely. We had actually just been to the asthma doctor. We were seeing somebody, had an action plan, and everybody knew what they had to do. Even with all of that, it still came to this. Benjamin still lost his life, and we never knew this was something that could happen,” stated Cristin Buckley, mother of Benjamin Buckley who was 7 years old at the time of his death. These testimonial videos will be used to raise awareness of the condition, and the importance of managing and monitoring symptoms.
Shared Decision Making Tool
Thank You to Our Supporters
The CHEST Foundation and Allergy and Asthma Network would like to thank our generous supporters, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, and Novartis for making this campaign possible. It is through supporters, who are active participants in helping grow this campaign, that these important materials are able to have an impact on patient outcomes and create long-lasting social change.
To view the campaign materials, visit us at asthma.chestnet.org.
CHEST Joint Congress in Basel, Switzerland
Members of CHEST leadership, faculty, and staff traveled to Basel, Switzerland, in June, to participate in the CHEST Joint Congress, which was co-hosted with the Swiss Respiratory Society, Schweizersche Gesellschaft Fur Pneumologie (SPG). Overall, there were approximately 1,100 total attendees, representing over 40 countries, who enjoyed the scientific program and gained valuable chest medicine knowledge.
The CHEST Joint Congress in Basel represented the second collaborative scientific conference endeavor with a third party, the first being the CHEST Conference held in Amsterdam May 6-9, COPD: Current Excellence and Future Development.
Members of CHEST leadership, faculty, and staff traveled to Basel, Switzerland, in June, to participate in the CHEST Joint Congress, which was co-hosted with the Swiss Respiratory Society, Schweizersche Gesellschaft Fur Pneumologie (SPG). Overall, there were approximately 1,100 total attendees, representing over 40 countries, who enjoyed the scientific program and gained valuable chest medicine knowledge.
The CHEST Joint Congress in Basel represented the second collaborative scientific conference endeavor with a third party, the first being the CHEST Conference held in Amsterdam May 6-9, COPD: Current Excellence and Future Development.
Members of CHEST leadership, faculty, and staff traveled to Basel, Switzerland, in June, to participate in the CHEST Joint Congress, which was co-hosted with the Swiss Respiratory Society, Schweizersche Gesellschaft Fur Pneumologie (SPG). Overall, there were approximately 1,100 total attendees, representing over 40 countries, who enjoyed the scientific program and gained valuable chest medicine knowledge.
The CHEST Joint Congress in Basel represented the second collaborative scientific conference endeavor with a third party, the first being the CHEST Conference held in Amsterdam May 6-9, COPD: Current Excellence and Future Development.
Ask PAs to Complete Survey on Joining 1st SVS ‘Section’
SVS President Dr. Clem Darling is asking all members to pass an email message – and survey – along to PAs and Nurse Practitioners with whom members work.
During the recent Vascular Annual Meeting, SVS leaders met with six physician assistants, all of whom work in vascular settings, and asked if they wish to work on establishing a home within the SVS. “Their response was a resounding and enthusiastic …YES!,” said Dr. Darling.
The group has now become the Steering Committee organizing the effort to create the historic first "Section" of the SVS.
SVS President Dr. Clem Darling is asking all members to pass an email message – and survey – along to PAs and Nurse Practitioners with whom members work.
During the recent Vascular Annual Meeting, SVS leaders met with six physician assistants, all of whom work in vascular settings, and asked if they wish to work on establishing a home within the SVS. “Their response was a resounding and enthusiastic …YES!,” said Dr. Darling.
The group has now become the Steering Committee organizing the effort to create the historic first "Section" of the SVS.
SVS President Dr. Clem Darling is asking all members to pass an email message – and survey – along to PAs and Nurse Practitioners with whom members work.
During the recent Vascular Annual Meeting, SVS leaders met with six physician assistants, all of whom work in vascular settings, and asked if they wish to work on establishing a home within the SVS. “Their response was a resounding and enthusiastic …YES!,” said Dr. Darling.
The group has now become the Steering Committee organizing the effort to create the historic first "Section" of the SVS.
Claim 2017 VAM Credits
Here’s how to claim Continuing Medical Education or MOC credits from the 2017 Vascular Annual Meeting.
1 Access the CME site, either through the Mobile App or through the website link: www.vsweb.org/ClaimCME
2 Log in, using either:
1 Last name and email address tied to your VAM registration OR
2 Registration ID number (no hyphens), located on registration confirmation or ID badges.
3 Follow the directions to list sessions, provide evaluations, take exams and generate credit certificates.
(Please note that the RPVI self-assessment process requires you to log in from a laptop or desktop computer.)
Credits must be claimed by Dec. 31. For more information, email [email protected].
Here’s how to claim Continuing Medical Education or MOC credits from the 2017 Vascular Annual Meeting.
1 Access the CME site, either through the Mobile App or through the website link: www.vsweb.org/ClaimCME
2 Log in, using either:
1 Last name and email address tied to your VAM registration OR
2 Registration ID number (no hyphens), located on registration confirmation or ID badges.
3 Follow the directions to list sessions, provide evaluations, take exams and generate credit certificates.
(Please note that the RPVI self-assessment process requires you to log in from a laptop or desktop computer.)
Credits must be claimed by Dec. 31. For more information, email [email protected].
Here’s how to claim Continuing Medical Education or MOC credits from the 2017 Vascular Annual Meeting.
1 Access the CME site, either through the Mobile App or through the website link: www.vsweb.org/ClaimCME
2 Log in, using either:
1 Last name and email address tied to your VAM registration OR
2 Registration ID number (no hyphens), located on registration confirmation or ID badges.
3 Follow the directions to list sessions, provide evaluations, take exams and generate credit certificates.
(Please note that the RPVI self-assessment process requires you to log in from a laptop or desktop computer.)
Credits must be claimed by Dec. 31. For more information, email [email protected].
Get involved with AGA
We’re soliciting members to serve in AGA leadership positions – as committee and center members, as well as on the AGA Institute Governing Board. This is an opportunity to network with other physicians and scientists, pursue a special interest, and make an impact in an area that is important to you.
Join a committee or center
AGA and AGA Institute are seeking members to serve on several committees and centers that recommend and oversee new and existing policies and programs. Terms will start in June 2018; nominations must be received by Nov. 1, 2017. Members can either nominate themselves or other members. For more information on the positions available, take a look at the AGA Committee page, http://www.gastro.org/about/people/committees.
Serve in a leadership position
The AGA Nominating Committee is in the midst of identifying candidates to join the governing board – in the offices of vice president, clinical research councillor, and practice councillor – as well as 10 nominees for the 2018-2019 AGA Nominating Committee. To learn more, or to nominate yourself or a colleague, email [email protected]. Nominations are due by Oct. 1, 2017; earlier submissions are encouraged.
We’re soliciting members to serve in AGA leadership positions – as committee and center members, as well as on the AGA Institute Governing Board. This is an opportunity to network with other physicians and scientists, pursue a special interest, and make an impact in an area that is important to you.
Join a committee or center
AGA and AGA Institute are seeking members to serve on several committees and centers that recommend and oversee new and existing policies and programs. Terms will start in June 2018; nominations must be received by Nov. 1, 2017. Members can either nominate themselves or other members. For more information on the positions available, take a look at the AGA Committee page, http://www.gastro.org/about/people/committees.
Serve in a leadership position
The AGA Nominating Committee is in the midst of identifying candidates to join the governing board – in the offices of vice president, clinical research councillor, and practice councillor – as well as 10 nominees for the 2018-2019 AGA Nominating Committee. To learn more, or to nominate yourself or a colleague, email [email protected]. Nominations are due by Oct. 1, 2017; earlier submissions are encouraged.
We’re soliciting members to serve in AGA leadership positions – as committee and center members, as well as on the AGA Institute Governing Board. This is an opportunity to network with other physicians and scientists, pursue a special interest, and make an impact in an area that is important to you.
Join a committee or center
AGA and AGA Institute are seeking members to serve on several committees and centers that recommend and oversee new and existing policies and programs. Terms will start in June 2018; nominations must be received by Nov. 1, 2017. Members can either nominate themselves or other members. For more information on the positions available, take a look at the AGA Committee page, http://www.gastro.org/about/people/committees.
Serve in a leadership position
The AGA Nominating Committee is in the midst of identifying candidates to join the governing board – in the offices of vice president, clinical research councillor, and practice councillor – as well as 10 nominees for the 2018-2019 AGA Nominating Committee. To learn more, or to nominate yourself or a colleague, email [email protected]. Nominations are due by Oct. 1, 2017; earlier submissions are encouraged.
Mark your calendar: 2018 AGA grants cycle announced
The AGA Research Foundation is excited to announce the start of its 2018 Research Grants cycle. This year the foundation will be awarding over $2 million in funding to support researchers within gastroenterology and hepatology. Now is your chance to view upcoming opportunities and plan your applications. Learn more below about the first application due in August, and visit the AGA Research Funding website (www.gastro.org/research-funding) for the full list. Contact [email protected] with any questions.
Applications due: Aug. 4, 2017
AGA-R. Robert & Sally Funderburg Research Award in Gastric Cancer
This award provides $50,000 per year for 2 years to an established investigator working on novel approaches in gastric cancer research. For the past 25 years, this $100,000 award has enhanced the fundamental understanding of gastric cancer pathobiology toward ultimately developing a cure for the disease.
The AGA Research Foundation is excited to announce the start of its 2018 Research Grants cycle. This year the foundation will be awarding over $2 million in funding to support researchers within gastroenterology and hepatology. Now is your chance to view upcoming opportunities and plan your applications. Learn more below about the first application due in August, and visit the AGA Research Funding website (www.gastro.org/research-funding) for the full list. Contact [email protected] with any questions.
Applications due: Aug. 4, 2017
AGA-R. Robert & Sally Funderburg Research Award in Gastric Cancer
This award provides $50,000 per year for 2 years to an established investigator working on novel approaches in gastric cancer research. For the past 25 years, this $100,000 award has enhanced the fundamental understanding of gastric cancer pathobiology toward ultimately developing a cure for the disease.
The AGA Research Foundation is excited to announce the start of its 2018 Research Grants cycle. This year the foundation will be awarding over $2 million in funding to support researchers within gastroenterology and hepatology. Now is your chance to view upcoming opportunities and plan your applications. Learn more below about the first application due in August, and visit the AGA Research Funding website (www.gastro.org/research-funding) for the full list. Contact [email protected] with any questions.
Applications due: Aug. 4, 2017
AGA-R. Robert & Sally Funderburg Research Award in Gastric Cancer
This award provides $50,000 per year for 2 years to an established investigator working on novel approaches in gastric cancer research. For the past 25 years, this $100,000 award has enhanced the fundamental understanding of gastric cancer pathobiology toward ultimately developing a cure for the disease.